Dabigatran etexilate (Pradaxa), an anticoagulant, works by:
A. inhibiting factor II (thrombin).
B. inhibiting the activation of vitamin K-dependent clotting factors II, VII, IX and X.
C. inhibition of factor Xa.
D. binding to antithrombin Ill to enhance the rate of neutralization of factors Il (thrombin) and Xa.
